Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Oct 11, 2023
The human immune system has a magnificent defense system that works continuously to protect the body from numerous infections and outside invaders. Maintaining a healthy immune response through the intricate interplay of cells, chemicals, and signaling pathways is essential for general health and well-being. Immuno...
Read More...
Nov 30, 2022
In recent years, the healthcare industry has witnessed immense growth in the screening and diagnostics segment. The incorporation of new-age technologies is bringing several life-saving revolutions to the market and improving the overall health outcomes for the patient. Digitization, innovation, newer hybrid busine...
Read More...
Dec 23, 2021
Sky receives FDA clearance to market the geko™ device for venous insufficiency and ischemia On December 16, 2021, Sky Medical Technology Ltd, a medical device company, got approval from the US Food and Drug Administration (FDA) 510(k) to market the geko™ device for growing microcirculatory bl...
Read More...
Aug 12, 2020
Infectious diseases or communicable diseases are one of the leading causes of death worldwide. These diseases are spread by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi. Infectious diseases possess greater risk as these diseases can easily transfer from human to human or by other modes....
Read More...
Jul 21, 2020
AstraZeneca demonstrates positive early results from its trial evaluating COVID-19 vaccine-AZD1222 In a frenzied race to find a global cure for COVID-19, several pharma players are testing waters and presenting results from clinical studies evaluating their potential candidates. Not long after, Moderna, a U...
Read More...
Aug 27, 2014
DelveInsight is helping worldwide Pharmaceutical companies with its Market Intelligence Reports. VISIT OUR WEBSITE Infectious Diseases and Vaccines The infectious disease (ID) vaccine pipeline is rich and robust. However, indications such as HIV, Tuberculosis and HCV have high demand for the development of a fi...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper